ArticleDiscover oncology2025
Horseshoe kidney with renal parenchymal squamous cell carcinoma: a case report and comprehensive literature review.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ureteric squamous cell carcinoma in a duplex collecting system presenting with chronic obstructive uropathy: a rare case report.International journal of surgery case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Horseshoe kidney (HSK) complicated with renal parenchymal squamous cell carcinoma (RSCC) is exceedingly rare and clinically insidious. Owing to the absence of pathognomonic symptoms or imaging hallmarks, the malignancy is frequently obscured by coexistent renal calculi, hydronephrosis, or infection, resulting in formidable diagnostic challenges, missed diagnoses, and consequently delayed treatment. We report a 60-year-old man who presented with HSK, left renal calculi, and hydronephrosis. After comprehensive preoperative evaluation, laparoscopic radical nephrectomy with isthmic transection was performed; histopathology confirmed a moderately to well-differentiated RSCC. A systematic literature review contextualizes this exceptional association. Clinicians should maintain a high index of suspicion for RSCC in HSK patients with long-standing calculi or anatomical anomalies who present with refractory flank pain. Early radical nephrectomy with regional lymphadenectomy remains the treatment of choice. Immunotherapy holds promise, yet its efficacy requires validation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.